'Predictive marker' presentation slideshows

ASCO 2010 Biomarker-driven Treatment in Stage II Colon Cancer: When to Hold and When to Fold

ASCO 2010 Biomarker-driven Treatment in Stage II Colon Cancer: When to Hold and When to Fold. Overview of adjuvant clinical trials in stage II colon cancer - results, challenges, and confusion. - Al B. Benson, III, MD

641 views • 45 slides

Introduction

K-RAS mutation status associated with clinical outcome in metastatic colorectal cancer patients treated with 5-fluorouracil/oxaliplatin

104 views • 1 slides

Table 2 Studies of the VEGF pathway as a predictive marker in breast cancer

138 views • 1 slides